Initially identified in gastric cancer, FER1L4 has since been reported to be an oncogene by modulating the PI3K/AKT pathway in various cancer cells, including osteosarcoma, hepatocellular carcinoma, and colon cancer. This evidence concerns the gene AKT1 and colonic neoplasm.